The authors argue that psychedelic medicine should be considered alongside the histories of drug policy, racism, criminalization and Indigenous knowledge.
What the authors examined
The commentary examines “psychedelic exceptionalism” — the idea that psychedelics should be treated as fundamentally different from other drugs affected by prohibition and criminalization. It considers that idea alongside the history of the war on drugs and the use of Indigenous knowledge in psychedelic medicine.
What the authors argue
Gaughan and James argue that psychedelic research and medicine should account for the racialized history of the war on drugs and for the knowledge and interests of Indigenous communities connected to some psychedelic medicines.
Their analysis places antiracism and decolonization within broader discussions of ethics in the field.
What this helps us understand
The commentary shows how the framing of psychedelic medicine changes when drug policy, criminalization and Indigenous knowledge are included in the analysis. For researchers, communicators and institutions, it offers a way to examine not only the clinical evidence but also the historical assumptions used to describe the field.
